Moneycontrol
    Moneycontrol PRO
    Loans
    Loans

    Jump to

    • Expect margin to sustain between 15-16% for next few quarters: Jyothy Labs

    • Completely geared up for launch of ayurveda products: Jyothy Labs

    • Got GST rate net benefit of about 4%; have passed it to customers: Jyothy Lab

    • Expect 50% gross margins for FY18: Jyothy Laboratories

    • Will clarify on Henkel deal by October 31: Jyothy Laboratories

    • Jyothy Laboratories hopeful of growing 10-12% in FY18

    • See demand uptick after initial cash ban shocker: Jyothy Labs

    • Henkel deal not done yet, will make strategic sense: Jyothy Labs

    • Expect double digit growth in FY17: Jyothy Labs

    • See company growing ahead of peers in coming quarters:Jyothy Lab

    • Expect strong Q3 volume growth, over 15% margins: Jyothy

    • Ujala has no competiton; saw good growth in Q2: Jyothy Labs

    • Aiming for 10-12% volume growth in FY16: Jyothy Labs

    • Eyeing EBITDA growth of 35% for FY15: Jyothy Laboratories

    • See H2 13-14% EBITDA margin; 20% FY15 profit growth: Jyothy

    • FY15 revenue growth seen at 20%: Jyothy Laboratories

    • Hope to maintain 15% EBITDA margin going ahead: Jyothy Labs

    • Debt-free Jyothy Labs reveals its acquisition plans

    • Expect topline to grow by 22-25% in FY14: Jyothy Lab

    • Will maintain 20-25% topline growth for FY14: Jyothy Labs

      According to Ullas Kamath, the company is seeing robust volume growth in the semi urban and rural and will hold on to its guidance of 20 percent upward on the topline growth for FY14.

    • Will achieve guidance despite stiff competition: Jyothy Lab

      Jyothy Laboratories today posted two-fold increase in net profit to Rs 28.70 crore for the first quarter ended June 30, 2013. Ullas Kamath, Joint Managing Director of the company told CNBC-TV18 that it has given the guidance of 20-25 percent on topline and 15 percent EBITDA margins.

    • Expect 14-15% EBITDA margins for FY14: Jyothy Labs

      For Jyothy Labs they have a fantasttic team in place, products in place, integration too is complete and good cash flows too are coming in, therefore they are now ready to do their best, adds Ullas Kamath of Jyothy Laboratories.

    • Jyothy Labs expects 25% sales growth in FY14

      Soaps and detergent maker Jyothy Laboratories expects its topline to rise 25 percent year-on-year in FY2014, as it expands into new geographies and products, Ullas Kamath, Joint MD, said on Friday.

    • See 25% topline and bottomline growth in FY13: Jyothy Labs

      K Ullas Kamath, deputy managing director of Jyothy Laboratories sees 25% top-line growth and 25% bottom-line growth in FY13.

    • Expect 25% growth in standalone profit in FY13: Jyothy Labs

      K Ullas Kamath, deputy managing director, Jyothy Laboratories says, he expects the company to grow standalone top-line and bottom-line by 25% for the entire year.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347